BioNTech SE (ETR:22UA)
82.75
+1.80 (2.22%)
At close: Sep 19, 2025
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€425,044
Profits / Employee
€50,916
Market Cap
19.69B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6,772 | 639 | 10.42% |
Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
Dec 31, 2020 | 1,941 | 631 | 48.17% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
BioNTech SE News
- 8 days ago - BioNTech (BNTX) Stock Dips Amid Vaccine Safety Concerns - GuruFocus
- 8 days ago - Why BioNTech Stock Sank by More Than 7% Today - The Motley Fool
- 8 days ago - Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths - Benzinga
- 8 days ago - COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says - Market Watch
- 8 days ago - BioNTech (BNTX) Shares Decline by Nearly 10% - GuruFocus
- 12 days ago - Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults - Benzinga
- 12 days ago - BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy - Benzinga
- 12 days ago - BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy - Benzinga